| P2093 | author name string | M. Tanaka | |
| | M. Watanabe | |
| | S. Kobayashi | |
| | T. Aoki | |
| | T. Tateishi | |
| | T. Kumai | |
| | H. Nakura | |
| P2860 | cites work | Molecular Pharmacology | Q1943386 |
| | Identification of the enzyme responsible for oxidative halothane metabolism: implications for prevention of halothane hepatitis | Q28610007 |
| | Human cytochrome P-450 enzymes | Q36079925 |
| | Clinical Pharmacokinetics of Lignocaine | Q39725309 |
| | The effect of halothane on drug disposition: contribution of changes in intrinsic drug metabolizing capacity and hepatic blood flow | Q44145998 |
| | Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane. | Q51654852 |
| | Lidocaine metabolism in human liver microsomes by cytochrome P450IIIA4. | Q51747037 |
| | MAC for halothane, enflurane, and isoflurane in the New Zealand white rabbit: and a test for the validity of MAC determinations. | Q51830109 |
| | Proliferation of Smooth Endoplasmic Reticulum and Induction of Microsomal Drug-metabolizing Enzymes after Ether or Halothane | Q52705978 |
| | Interaction of volatile anesthetics with rat hepatic microsomal cytochrome P-450. | Q52721408 |
| | Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1 | Q67260608 |
| | Concentration Dependence of Hepatic Halothane Metabolism | Q71759832 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | halothane | Q32921 |
| P304 | page(s) | 199-203 | |
| P577 | publication date | 1997-07-01 | |
| P1433 | published in | Anesthesia & Analgesia | Q72225 |
| P1476 | title | Halothane Inhalation Inhibits the Metabolism of Chlorzoxazone, a Substrate for CYP2E1, in Rabbits | |
| P478 | volume | 85 | |